Mayne Pharma Group Limited (ASX:MYX)

Mayne Pharma Group Revenue

Mayne Pharma Group had revenue of 212.07M AUD in the half year ending December 31, 2025, with 12.85% growth. This brings the company's revenue in the last twelve months to 407.11M, down -1.55% year-over-year. In the fiscal year ending June 30, 2025, Mayne Pharma Group had annual revenue of 408.10M with 5.07% growth.

• Revenue (ttm): 407.11M
• Revenue Growth: -1.55%
• P/S Ratio: 0.46
• Revenue / Employee: 829.15K
• Employees: 491
• Market Cap: 185.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	408.10M	19.70M	5.07%
Jun 30, 2024	388.40M	204.81M	111.56%
Jun 30, 2023	183.59M	26.44M	16.82%
Jun 30, 2022	157.15M	-243.63M	-60.79%
Jun 30, 2021	400.78M	-56.20M	-12.30%